Dental Care Clinics in Byram, MS Accepting Medicare
8 Dental Care Clinics found. Showing 1 - 8
 James B Carr, Dmd, Pllc Dentist Medicare: Not Enrolled in Medicare Practice Location: 7278 S Siwell Rd Ste B, Byram, MS 39272 Phone: 601-371-7156 Fax: 601-373-8485 |
Dulaney Dental, Pllc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 310 Byram Pl Ste C, Byram, MS 39272 Phone: 601-373-1351 Fax: 601-372-7029 |
Southern Family Dental Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 115 Bridgeton Plz, Byram, MS 39272 Phone: 601-373-4500 Fax: 662-586-2995 |
Siwell Dental Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 6745 S. Siwell Rd., Suite 210, Byram, MS 39272 Phone: 601-371-8634 Fax: 601-371-8724 |
Prestige Dental Care Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 7138 S Siwell Road, Byram, MS 39272 Phone: 601-533-0923 Fax: 601-351-5609 |
Southern Family Dentistry Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 115 Bridgeton Plz, Byram, MS 39272 Phone: 601-373-4500 Fax: 601-373-4503 |
Gary Williams Llc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 100 Marketplace Dr Ste B, Byram, MS 39272 Phone: 601-665-4809 Fax: 769-230-4973 |
Siwell Road Dental, Pllc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 7278 S Siwell Rd, Byram, MS 39272 Phone: 601-271-8710 |
News Archive
Household odorant smell tests could help detect COVID-19, say study
Researchers at the Weizmann Institute of Science and other institutions developed a new tool to help detect COVID-19 infection. The team developed and tested a real-time tool to measure olfactory perception impairment by asking the participants to smell household odorants.
New approach to cancer immunotherapy may prevent autoimmunity
A team of researchers has found disrupting the interaction between cancer cells and certain immune cells is more effective at killing cancer cells than current immunotherapy treatments.
Mylan settles Vivelle-Dot patent litigation lawsuit with Novartis
Mylan Inc. today announced that it has settled a patent litigation lawsuit with Novartis Pharmaceuticals Corporation related to Vivelle-Dot® (Estradiol Transdermal System USP, Twice-Weekly, 0.025 mg/day, 0.0375 mg/day, 0.05 mg/day and 0.075 mg/day and 0.1 mg/day).
New interoperability standards for diabetes devices
JDRF and the Centre for Global eHealth Innovation at the University Health Network in Toronto announced publication of interoperability standards for diabetes devices. The work is the result of JDRF Canadian Clinical Trial Network funding to Dr. Joseph Cafazzo at UHN to pilot the development of standard communication protocols that define how diabetes devices, such as insulin pumps, blood glucose meters, and continuous glucose monitors, communicate with one another and with other devices.
› Verified 8 days ago